More recently, a study demonstrated that infarct size was significantly decreased, cardiac contractile function was improved, CM death was markedly reduced, and myocardial fibrosis was lessened in mice with global S100A9 deficiency following I/R (Li et al., 2019), which suggests a detrimental role of S100A9. The gene discussed is S100A9; the disease is Myocardial fibrosis.